OVD Enterprise is verified as Nutanix Ready AHV. Inuvika’s own Eric Wing was invited to talk about Inuvika’s relationship with Nutanix, a leader in hyper convergence and cloud computing. Click here to visit the Guest Blog Post
Read more
April 30, 2017. Toronto, ON. Canada – Inuvika Inc. announced that it has appointed Hobart, Tasmania-based Virtual Information Technology Pty Ltd. as an authorized reseller partner. Inuvika OVD delivers virtualized Windows and Linux applications to anydevice, without the cost and complexity of traditional VDI solutions. Kevin Gallagher, CEO of Inuvika Inc. said, “We are pleased […]
Read more
OVD Enterprise Tested and Verified with Nutanix AHV Hypervisor April 10, 2017 Toronto, ON, Canada – Inuvika Inc. today announced that OVD Enterprise has been verified Nutanix Ready AHV on Nutanix’s leading Enterprise Cloud Platform. Together, Nutanix and Inuvika deliver end-to-end solutions for Virtualized Application Delivery. Being verified Nutanix Ready means that end users can be confident […]
Read more
Inuvika has released the Enterprise Desktop Client (EDC) for beta testing. The latest EDC introduces new capabilities such as bi-directional audio and performance improvements for Windows RDSH hosted applications. Through the support of Microsoft RemoteFX, the new client delivers advanced coding and graphics virtualization. With dynamic adaptation to various runtime conditions, such as graphic content types; […]
Read more
Toronto, Canada – Inuvika, the leading open source software vendor for application delivery, announced today that it has appointed Prianto USA as a North American distribution partner. Inuvika’s OVD Enterprise (OVD) is an application and desktop virtualization platform that supports Windows RDS and Linux, enabling seamless delivery to any client running Windows, Linux, Android, MacOS […]
Read more
Toronto, ON – Genomics England is creating a new genomic medicine service for the UK National Health Service (NHS). With the aim of enabling new scientific discoveries and medical insights, the 100,000 Genomes Project will ultimately sequence 100,000 genomes from around 70,000 NHS patients and their families with rare diseases and cancers. When completed, the NHS will […]
Read more